SCHEMBL674596

SCHEMBL674596

NS(=O)(=O)c1ccc(NC(=O)Nc2ccccc2C(F)(F)F)cc1

nearest known ligand 0.79

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA1 P00915 17/20 0.79
CA2 P00918 17/20 0.79
CA9 Q16790 17/20 0.79
CA12 O43570 15/20 0.79
CYP1A2 P05177 2/20 0.69
MAPT P10636 1/20 0.66
CA7 P43166 3/20 0.63
KMT2A Q03164 2/20 0.62
POLB P06746 1/20 0.62
KDM4E B2RXH2 1/20 0.60
MEN1 O00255 1/20 0.60
NPC1 O15118 1/20 0.60
ALDH1A1 P00352 1/20 0.60
THRB P10828 1/20 0.60
RAB9A P51151 1/20 0.60
NOX1 Q9Y5S8 1/20 0.60
CA4 P22748 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL672980 0.88 CA1 (1.00) CA1CA2CA9CA12CYP1A2
SCHEMBL7759976 0.82 MEN1 (0.68) MAPTKMT2APOLBKDM4EMEN1
SCHEMBL672763 0.82 CA12 (1.00) CA1CA2CA9CA12CYP1A2
SCHEMBL7172778 0.81 CA2 (0.56) CA1CA2CA9CA12CYP1A2
SCHEMBL4554988 0.80 KMT2A (0.69) CA1CA2CA9CA12MAPT
SCHEMBL13193500 0.80 ALDH1A1 (0.69) CYP1A2MAPTKMT2APOLBKDM4E
SCHEMBL668108 0.80 CA1 (1.00) CA1CA2CA9CA12MAPT
SCHEMBL671546 0.79 CA2 (1.00) CA1CA2CA9CA12CYP1A2
SCHEMBL7877742 0.79 MEN1 (0.64) MAPTKMT2APOLBKDM4EMEN1
SCHEMBL3406989 0.79 CA2 (0.70) CA1CA2CA9CA12CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590938-A1 NOVEL SULFONAMIDE COMPOUNDS FOR INHIBITION OF METASTATIC TUMOR GROWTH Metasignal Therapeutics Inc. (CA) 2013-05-15 EP claimed
WO-2012021963-A1 NOVEL SULFONAMIDE COMPOUNDS FOR INHIBITION OF METASTATIC TUMOR GROWTH METASIGNAL THERAPEUTICS INC. (CA) 2012-02-23 WO claimed
EP-2590938-A1 NOVEL SULFONAMIDE COMPOUNDS FOR INHIBITION OF METASTATIC TUMOR GROWTH Metasignal Therapeutics Inc. (CA) 2013-05-15 EP disclosed
WO-2012021963-A1 NOVEL SULFONAMIDE COMPOUNDS FOR INHIBITION OF METASTATIC TUMOR GROWTH METASIGNAL THERAPEUTICS INC. (CA) 2012-02-23 WO disclosed